Corporate Information

A global medicinal cannabis company improving the quality of peoples' lives

TSXV: KHRN | OTCQX: KHRNF | Frankfurt: A2JMZC

Download Presentation

130%

4,600 Medical Cannabis Prescriptions* Filled in LatAm

3

Established medical sales in three countries: Colombia, UK and Peru

15%

Of our consults are done through telehealth in wholly-owned clinics

9.5K

Monthly patient consultations at Khiron wholly owned clinics

Icon

Our Mission

To improve the quality of life of patients and consumers through the applied use of cannabis and technology.

Icon

Our Vision

To reach 1 million patients and consumers by 2024.

Khiron

OUR CLINICS

Khiron Health Services is implementing a new healthcare model to treat patients worldwide through a network of integrative health centers.

In the domestic market of Colombia and elsewhere in Latin America, Khiron Life Sciences has built partnerships with some of the region’s most respected medical associations. In coordination with these associations, a growing regional network of physicians is being created to serve as the primary distribution channel.

Phone

15%

Our custom-built telehealth platform accounts for 15% of total patient consultations

3

Wholly-owned locations

450%

450% QoQ growth in medical cannabis prescriptions

28+

28+ healthcare specialists trained to prescribe medical cannabis in Colombia

Phone

We believe in the benefits of medical cannabis to improve health condition in patients

Khiron’s products are manufactured in GMP-GEP compliant facilities in Colombia. Our produts are standardized and stabilized according to the U.S. Pharmacopeia analytics standard (USP42).

Learn More
3

Up to 3 tonnes of full-spectrum extract capacity

3

Sales in over 3 countries (Colombia, Peru, UK)

4+

4+ SKU’s for medical cannabis products

3+

3+ European partnerships: Project Twenty21 and MCCS in the UK, Nimbus Health in Germany

OUR WELLBEING PRODUCTS

We believe cannabis ingredients and hemp seeds have the potential to create a massive consumer products market.

At the core of Khiron’s wellbeing unit, the first LatAm mass-market branded CBD skincare line Kuida is distributed at retail and online stores across Colombia, UK, Spain and in permissive states in the United States. Khiron’s wellbeing unit believes in the power of cannabis and hemp seeds to be disruptors in the development of high quality mass-consumption products.

Learn More
3

Sales across 3 continents

11

SKUs sold in 5 countries and 4 continents

30%

30% of sales through digital channels

GLOBAL EXPANSION

Khiron is well positioned to capitalize on the global medical cannabis market.

OUR CULTIVATION SITE

Cultivation: More than 9 tonnes¹ of dry flower. Fully licensed for commercial THC and CBD cultivation, extraction & sales in Colombia.

  • Total area of 20 Ha. Current cultivation area of 80,000 sq. ft.
  • Obtained 17% of Colombia’s total allocation of THC quotas for 2020, 1st company to do so in Colombia.
  • ~1 MW Solar Park resulting in up to 40% energy cost reduction.

Icon

Our Laboratory

  • State-of-the-art, 14,000 sq.ft. GMP-compliant post-harvest facility in Doima, Colombia (157 km. West of Bogota)
  • Extraction: Up to 3 tonnes of full-spectrum extract, with capacity to expand within building.

Leadership Dots

KHIRON LIFE SCIENCES has a highly experienced management team and influential board representation including the 55th president of Mexico and former CEO of Coca Cola Mexico, Vicente Fox and Deborah Rosati who is the Founder & CEO of Women Get On Board, a leading member-based company that connects, promotes and empowers women to corporate boards.


Contact Us

Have business-related questions about KHRN? Or just general inquiries? Send us a message and we ́ll be happy to help.

Register Now

Be the first to try our products when they become available. Read our Privacy Policy.

Sign up for Email Alerts